Medivir: Interim Report 2016 (Medivir) - Aug 21, 2016 - Anticipated presentation of interim data from P2a trial (NCT02569710) of simeprevir in combination with odalasvir and AL-335 for hepatitis C infection at EASL-AASLD (Sep 23-24, 2016); Anticipated completion of P2 trial of simeprevir in combination with odalasvir and AL-335 for hepatitis C infection by end 2016
Anticipated P2a data • Anticipated trial completion date • Hepatitis C Virus
|